Țară: Canada
Limbă: engleză
Sursă: Health Canada
INDOCYANINE GREEN
NOVADAQ TECHNOLOGIES ULC
V04CX01
INDOCYANINE GREEN
25MG
KIT
INDOCYANINE GREEN 25MG
INTRAVENOUS
15G/50G
Ethical
ROENTGENOGRAPHY
Active ingredient group (AIG) number: 0150962001; AHFS:
APPROVED
2020-05-01
SPY AGENT™ GREEN Indocyanine Green for Injection, USP 25 mg/vial Lyophilized powder for intravenous or interstitial injection Fluorescent Imaging Agent Novadaq Technologies ULC (a part of Stryker) 8329 Eastlake Drive, Unit 101 Burnaby, British Columbia V5A 4W2 Date of Initial Approval: December 5, 2018 Date of Revision: June 2, 2022 Submission Control No: 259784 Page 2 of 20 TABLE OF CONTENTS TABLE OF CONTENTS .......................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION............................................................... 4 1 INDICATIONS.............................................................................................................. 4 1.1 Pediatrics ....................................................................................................... 4 1.2 Geriatrics ....................................................................................................... 4 2 CONTRAINDICATIONS ............................................................................................... 4 3 DOSAGE AND ADMINISTRATION .............................................................................. 5 3.1 Dosing Considerations ................................................................................... 5 3.2 Recommended Dose and Dosage Adjustment ................................................ 5 3.3 Administration ................................................................................................ 6 3.4 Reconstitution ................................................................................................ 7 3.5 Missed Dose .................................................................................................. 7 4 OVERDOSAGE ........................................................................................................... 7 5 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING ........................ 8 6 WARNINGS AND PRECAUTIONS .................................. Citiți documentul complet